The Prevention and Control Program has two broad goals: to develop and conduct research across the cancer continuum that is transdisciplinan/ in nature and translational in focus. Our transdisciplinary research spans from cell to society to address key problems in cancer prevention and control, including disparities, communication, tobacco control, and energy balance. Our translational research evaluates efforts to implement and disseminate evidence-based cancer control into clinical and public health practice, and health policy. To achieve these goals, the Prevention and Control Program: 1. Provides scientific leadership that identifies and actively promotes opportunities for trandisciplinary and translational cancer prevention and control science; 2. Recruits and supports new scientific talent with interests and experience in the two goal areas; 3. Assembles and supports transdisciplinary teams across the Cancer Center; 4. Coordinates seminars, workshops and trainings that help shape the research ideas and skills of cancer prevention and control researchers;and. Builds community partnerships to assure Cancer Center research is responsive to local needs, conducted in real world settings and accountable for timely translation of research into practice. Leading-edge research is underway across the Program;examples include studies examining and reducing breast cancer disparities, integrating communication into cancer care, and exploring ways to improve tobacco control from genetics to social systems. The Prevention and Control Program has 53 members from 11 Departments and 3 Schools (Washington University School of Medicine, Washington University School of Social Work, Saint Louis University). The Program is supported by $24,751,020 in funding of which $11,901,857 is NCI funding and $9,775,280 is other peer reviewed funding. In the last grant period, members of the Program published 480 manuscripts, of which 14.7% represent inter-programmatic and 37.9% resulted from intra-programmatic collaborations.
Cancer continues to pose a major threat to public health. Leading-edge transdisciplinary and translational research is underway across the Prevention and Control Program to reduce this threat by eliminating breast cancer disparities, integrating communication into cancer care, improving tobacco control, energy balance and maximize the benefits of cancer genetics research for cancer prevention.
|Johnson, Kimberly J; Zoellner, Nancy L; Gutmann, David H (2016) Peri-gestational risk factors for pediatric brain tumors in Neurofibromatosis Type 1. Cancer Epidemiol 42:53-9|
|Zuiani, Adam; Chen, Kevin; Schwarz, Megan C et al. (2016) A Library of Infectious Hepatitis C Viruses with Engineered Mutations in the E2 Gene Reveals Growth-Adaptive Mutations That Modulate Interactions with Scavenger Receptor Class B Type I. J Virol 90:10499-10512|
|Abboud, Ramzi; Keller, Jesse; Slade, Michael et al. (2016) Severe Cytokine-Release Syndrome after T Cell-Replete Peripheral Blood Haploidentical Donor Transplantation Is Associated with Poor Survival and Anti-IL-6 Therapy Is Safe and Well Tolerated. Biol Blood Marrow Transplant 22:1851-60|
|Durai, Vivek; Murphy, Kenneth M (2016) Functions of Murine Dendritic Cells. Immunity 45:719-736|
|Brownson, Ross C; Dodson, Elizabeth A; Kerner, Jon F et al. (2016) Framing research for state policymakers who place a priority on cancer. Cancer Causes Control 27:1035-41|
|Chou, Chun; Verbaro, Daniel J; Tonc, Elena et al. (2016) The Transcription Factor AP4 Mediates Resolution of Chronic Viral Infection through Amplification of Germinal Center B Cell Responses. Immunity 45:570-82|
|Niu, Haixia; Hadwiger, Gayla; Fujiwara, Hideji et al. (2016) Pathways of retinoid synthesis in mouse macrophages and bone marrow cells. J Leukoc Biol 99:797-810|
|Beeman, Scott C; Shui, Ying-Bo; Perez-Torres, Carlos J et al. (2016) O2 -sensitive MRI distinguishes brain tumor versus radiation necrosis in murine models. Magn Reson Med 75:2442-7|
|Mertins, Philipp; Mani, D R; Ruggles, Kelly V et al. (2016) Proteogenomics connects somatic mutations to signalling in breast cancer. Nature 534:55-62|
|Murphy, Theresa L; Grajales-Reyes, Gary E; Wu, Xiaodi et al. (2016) Transcriptional Control of Dendritic Cell Development. Annu Rev Immunol 34:93-119|
Showing the most recent 10 out of 947 publications